Mesirow Institutional Investment Management, Inc. Amicus Therapeutics, Inc. Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.27 Billion
- Q4 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 89,382 shares of FOLD stock, worth $753,490. This represents 0.07% of its overall portfolio holdings.
Number of Shares
89,382
Previous 81,752
9.33%
Holding current value
$753,490
Previous $873,000
3.67%
% of portfolio
0.07%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$247 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$205 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$204 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$195 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$131 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.36B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...